Rantec 150 mg (Tablet)

Unit Price: ৳ 2.00 (100's pack: ৳ 200.00)

Medicine Details

Category Details
Generic Ranitidine hydrochloride
Company Medimet pharmaceuticals ltd
Also available as
Rantec 300 mg tablet

Title

Rantec Medicine

Categories

  • Gastric Medication
  • Gastrointestinal Health
  • Duodenal Ulcer Treatment

Description

Rantec is a medication indicated for the treatment of active duodenal ulcer, benign gastric ulcer, ulcer associated with non-steroidal anti-inflammatory agent, post-operative stress ulcer, Zollinger-Ellison Syndrome, and Gastroesophageal reflux disease (GERD). It competitively blocks histamine at H2-receptors of the gastric parietal cells, inhibiting gastric acid secretion without affecting pepsin secretion or serum gastrin. Dosage and administration vary based on the condition being treated.

Dimensions

N/A

Color Options

N/A

Functions

  • Treatment of active duodenal ulcer
  • Benign gastric ulcer treatment
  • Prevention of ulcer associated with non-steroidal anti-inflammatory agent
  • Post-operative stress ulcer prevention
  • Zollinger-Ellison Syndrome treatment
  • GERD treatment

Materials

Active ingredient: Ranitidine

Technical Specifications

  • Tablet & Syrup Dosage:
    • Duodenal and gastric ulcer:
      • 150 mg twice daily
      • 300 mg as a single daily dose at night for 4 to 8 weeks
    • Reflux oesophagitis:
      • 150 mg twice daily
      • 300 mg at bedtime for up to 8 weeks
    • Zollinger Ellison syndrome:
      • 150 mg 3 times daily, increase if necessary up to 6 g daily in divided doses
    • Episodic dyspepsia:
      • 150 mg twice daily
      • 300 mg at bedtime for up to 6 weeks
    • Maintenance: 150 mg at night for preventing recurrences
    • Child (peptic ulcer): 2-4 mg/kg twice daily, maximum 300 mg daily
    • IV Injection & IV Infusion: Dosage and administration as directed by a healthcare professional
  • Reconstitution:
    • Slow IV inj: Rantec 50 mg diluted to a concentration ≤2.5 mg/mL with specified injection solutions
    • Intermittent slow IV infusion: Rantec 50 mg diluted to a concentration ≤0.5 mg/mL with specified infusion solutions
    • Continuous IV infusion: Rantec 150 mg diluted in 250 mL of specified infusion solutions
    • Zollinger-Ellison syndrome: Rantec should be diluted to a concentration ≤2.5 mg/mL with specified infusion solutions

Design Elements

N/A

Usability Features

  • Pregnancy & Lactation: Use during pregnancy and lactation should be carefully considered
  • Precautions & Warnings: Reduced dosage for patients with impaired renal and hepatic function
  • Use in Special Populations: Use in elderly patients
  • Overdose Effects: Symptomatic and supportive therapy in case of overdosage

Indications

  • Active duodenal ulcer
  • Benign gastric ulcer
  • Ulcer associated with non-steroidal anti-inflammatory agent
  • Post-operative stress ulcer
  • Zollinger-Ellison Syndrome
  • Gastroesophageal reflux disease (GERD)
  • Gastrointestinal haemorrhage from stress ulcer in seriously ill patient
  • Recurrent haemorrhage in patients with bleeding peptic ulcer
  • Before general anesthesia in patient considered to be at risk of acid aspiration particularly obstetric patients

Interaction

  • Propantheline Bromide: Delayed absorption and increased peak serum concentration
  • Other drugs: May affect absorption and bioavailability of certain pH-dependent drugs

Contraindications

Patients hypersensitive to Ranitidine

Side Effects

  • Common: Altered bowel habit, dizziness, rash, tiredness
  • Rare: Reversible confusional states, headache, decreased blood counts, muscle or joint pain

Storage Conditions

Store in a cool and dry place, protect from light

Related Brands